alexa
Reach Us +1-504-608-239
Editor - James A Radosevich | University of Illinois | 18471
ISSN: 2577-0535

Journal of Cancer Clinical Trials
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Relevant Topics

James A Radosevich

James A Radosevich
James A Radosevich
Professor
University of Illinois
USA
University of Illinois

Biography

Dr. James A Radosevich is a Professor in the School of Dental Medicine at the University of Illinois at Chicago (UIC). From 1983 to 2004 he was an Assistant/Associate Professor and a Certified Clinical Investigator (ICH) at Northwestern University Medical School. He has consulted for numerous companies over the last thirty years, received numerous national grants/awards, and been involved in all aspects of drug development and clinical trials. Dr. Radosevich has been part of six start-up biotechnology/medical companies over the past thirty years and has a history of consistently beating performance milestones. He has held the positions of President, CEO, Chief Scientific Officer, and was the founder for five of these companies. Dr. Radosevich earned a B.S. degree in Biology at Bradley University in Peoria, Illinois in 1978 and a Ph.D. in Experimental Pathology at UIC in 1983. He completed his postdoctoral training at Northwestern University in Tumor Cell Biology, where he established his expertise in immune recognition, immune response, and various molecular and biochemical approaches in understanding the morphology, physiology, and cell biology of human cancer. He has edited three books, and has over four hundred published scientific papers, book chapters and abstracts, as well as 12 patents.

Research Interest

Tumor Cell Biology
Immune recognition
Immune response
Molecular and biochemical approaches in understanding the morphology, physiology, and cell biology of human cancer

Global Speakers in the subject

Global Experts in the subject

Leave Your Message 24x7
Top